An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology firm specializing in innovative therapeutics, has announced its participation in several upcoming investor conferences in November and December 2022. Notable events include the Cowen’s 6th Annual IO Next Summit on November 11 and the Jefferies London Healthcare Conference on November 17, among others. Live webcasts of the fireside chats will be available on the company’s website, with archived versions accessible for 90 days. Bicycle Therapeutics focuses on developing novel peptide-based medicines for underserved diseases.
Positive
None.
Negative
None.
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--
Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in November and December:
Cowen’s 6th Annual IO Next Summit on Friday, November 11, 2022; fireside chat at 9:10 a.m. ET
Jefferies London Healthcare Conference on Thursday, November 17, 2022; fireside chat at 8:00 a.m. GMT
Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022; fireside chat at 9:30 a.m. ET
Evercore ISI HealthCONx Conference on Thursday, December 1, 2022; fireside chat at 8:25 a.m. ET
Live webcasts of the fireside chats will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 90 days following the fireside chat dates.
About Bicycle Therapeutics Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTC®) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICA® targeting Nectin-4 and agonizing CD137, in company-sponsored Phase I/II trials. In addition, BT1718, a BTC that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial sponsored by the Cancer Research UK Centre for Drug Development. Bicycle is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Lexington, MA. For more information, visit bicycletherapeutics.com.
What investor conferences will Bicycle Therapeutics (BCYC) participate in during November 2022?
Bicycle Therapeutics will participate in the Cowen’s 6th Annual IO Next Summit on November 11, Jefferies London Healthcare Conference on November 17, Piper Sandler 34th Annual Healthcare Conference on November 29, and Evercore ISI HealthCONx Conference on December 1.
When will the fireside chat at Cowen’s 6th Annual IO Next Summit take place?
The fireside chat at Cowen’s 6th Annual IO Next Summit is scheduled for November 11, 2022, at 9:10 a.m. ET.
Where can I watch the webcasts for Bicycle Therapeutics (BCYC) conferences?
Live webcasts of the fireside chats will be available on Bicycle Therapeutics’ website, with archived replays accessible for 90 days post-event.
What are Bicycles in the context of Bicycle Therapeutics (BCYC)?
Bicycles are a novel class of medicines developed by Bicycle Therapeutics, consisting of fully synthetic short peptides that are constrained to form two loops, enhancing their binding affinity and selectivity for targets.
What is the focus of Bicycle Therapeutics' drug development?
Bicycle Therapeutics focuses on developing peptide-based drugs for diseases that are currently underserved by existing therapeutics, utilizing its proprietary bicyclic peptide technology.
Bicycle Therapeutics plc American Depositary Shares
